Oral Prednisolone in the Treatment of Esophageal Stricture After Esophageal Surgery

• Status: Unknown status
• Trial end date: 2019-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is safety and proof-of-concept study for oral prednisolone in the treatment of esophageal stricture after esophageal surgery. The patients who develop the severe esophageal strictures from 28 days after esophageal surgery are included. Primary outcomes are Safety and Success rate of this treatment.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nagasaki University
• Treatments: Methylprednisolone; Methylprednisolone acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate; Prednisone

Criteria

Inclusion Criteria:

• The patients who develop the severe esophageal strictures from 28 days after esophageal surgery

Exclusion Criteria:

• Pulmonary and cardiac disorders

• Liver and renal dysfunctions

• Allergic

• Pregnancy

• infectious disease

• Unsuitable condition